Cargando…
Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics
Increasing evidence suggests that interference with growth factor receptor tyrosine kinase (RTK) signaling can affect DNA damage response (DDR) networks, with a consequent impact on cellular responses to DNA‐damaging agents widely used in cancer treatment. In that respect, the MET RTK is deregulated...
Autores principales: | Bensimon, Ariel, Koch, Jonas P., Francica, Paola, Roth, Selina M., Riedo, Rahel, Glück, Astrid A., Orlando, Eleonora, Blaukat, Andree, Aebersold, Daniel M., Zimmer, Yitzhak, Aebersold, Ruedi, Medová, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266272/ https://www.ncbi.nlm.nih.gov/pubmed/32336009 http://dx.doi.org/10.1002/1878-0261.12696 |
Ejemplares similares
-
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
por: Orlando, Eleonora, et al.
Publicado: (2022) -
Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
por: Orlando, Eleonora, et al.
Publicado: (2023) -
A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response
por: Koch, Jonas P., et al.
Publicado: (2023) -
Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer
por: Piguet, Anne-Christine, et al.
Publicado: (2015) -
The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response — Biological and Clinical Aspects
por: Medová, Michaela, et al.
Publicado: (2013)